24-Week Trial Data Announced / Final Module Filed… In early July SANUWAVE (SNWV) announced that they had made the third and final module filing to the FDA for dermaPACE in the treatment of diabetic foot ulcers.   Also announced was 24-week data from SANUWAVE’s Phase III IDE study.  The data, along with the 12-week results, [...]